501 related articles for article (PubMed ID: 16418010)
21. Proteomic identification of salivary biomarkers of type-2 diabetes.
Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
23. The amplified peptidome: the new treasure chest of candidate biomarkers.
Geho DH; Liotta LA; Petricoin EF; Zhao W; Araujo RP
Curr Opin Chem Biol; 2006 Feb; 10(1):50-5. PubMed ID: 16418009
[TBL] [Abstract][Full Text] [Related]
24. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
Ray S; Reddy PJ; Jain R; Gollapalli K; Moiyadi A; Srivastava S
Proteomics; 2011 Jun; 11(11):2139-61. PubMed ID: 21548090
[TBL] [Abstract][Full Text] [Related]
25. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
26. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
[TBL] [Abstract][Full Text] [Related]
27. Human saliva proteome analysis.
Hu S; Loo JA; Wong DT
Ann N Y Acad Sci; 2007 Mar; 1098():323-9. PubMed ID: 17435138
[TBL] [Abstract][Full Text] [Related]
28. Comparison of protein enrichment strategies for proteome analysis of plasma.
Bandow JE
Proteomics; 2010 Apr; 10(7):1416-25. PubMed ID: 20127685
[TBL] [Abstract][Full Text] [Related]
29. Membrane proteomics: the development of diagnostics based on protein shedding.
Lai ZW; Steer DL; Smith AI
Curr Opin Mol Ther; 2009 Dec; 11(6):623-31. PubMed ID: 20072939
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the mouse serum proteome.
Hood BL; Zhou M; Chan KC; Lucas DA; Kim GJ; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2005; 4(5):1561-8. PubMed ID: 16212407
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Paul ion trap to the linear ion trap for use in global proteomics.
Riter LS; Gooding KM; Hodge BD; Julian RK
Proteomics; 2006 Mar; 6(6):1735-40. PubMed ID: 16475232
[TBL] [Abstract][Full Text] [Related]
32. Opportunities for sensitive plasma proteome analysis.
Landegren U; Vänelid J; Hammond M; Nong RY; Wu D; Ullerås E; Kamali-Moghaddam M
Anal Chem; 2012 Feb; 84(4):1824-30. PubMed ID: 22248085
[TBL] [Abstract][Full Text] [Related]
33. So, you want to look for biomarkers (introduction to the special biomarkers issue).
LaBaer J
J Proteome Res; 2005; 4(4):1053-9. PubMed ID: 16083254
[TBL] [Abstract][Full Text] [Related]
34. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
35. Advances in proximal fluid proteomics for disease biomarker discovery.
Teng PN; Bateman NW; Hood BL; Conrads TP
J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
[TBL] [Abstract][Full Text] [Related]
36. Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome.
Krasnoselsky AL; Faca VM; Pitteri SJ; Zhang Q; Hanash SM
J Proteome Res; 2008 Jun; 7(6):2546-52. PubMed ID: 18419151
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Fang X; Balgley BM; Lee CS
Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
[TBL] [Abstract][Full Text] [Related]
38. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
39. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
[TBL] [Abstract][Full Text] [Related]
40. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
